We value your privacy
We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.
Clinical Trials
12
2 active
Approvals
0
Total approvals
Agencies
Regulatory bodies
Founded
1919
Active, not recruiting
2
16.7%
Completed
7
58.3%
Recruiting
3
25.0%
No approval data available
- WVU Cancer Institute is the first to commercially use the FDA-approved 180° C2 Cryoballoon for Barrett's esophagus treatment, a precancerous condition. - The Cryoballoon offers a targeted, minimally invasive cryotherapy, freezing and eliminating abnormal esophageal cells with enhanced precision and safety. - The technology represents a significant advancement in endoscopic treatments, providing new possibilities for at-risk patients and effective treatment options. - The first patient treated with the device experienced a quick recovery, demonstrating the potential for improved patient outcomes and reduced recovery time.
